Simon Karpatkin

Simon Karpatkin's AcademicInfluence.com Rankings

Simon Karpatkin

Philosophy

#4681

World Rank

#7293

Historical Rank

Logic

#2088

World Rank

#2998

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Simon Karpatkin's Degrees

Doctorate Medicine New York University

Why Is Simon Karpatkin Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Simon Karpatkin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype. (2006) (477)
Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets. (1969) (437)
Autoimmune thrombocytopenic purpura. (1980) (425)
Autoimmune thrombocytopenic purpura in homosexual men. (1982) (374)
Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. (1988) (360)
Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets. (1969) (354)
On the mechanism of thrombocytopenic purpura in sexually active homosexual men. (1984) (289)
Role of platelets in tumor cell metastases. (1981) (262)
Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. (1991) (250)
Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. (1992) (226)
Use of the megathrombocyte as an index of megakaryocyte number. (1971) (216)
Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line. (1980) (212)
Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume. (1978) (210)
Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. (1998) (198)
Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis. (2004) (190)
In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosus. (1969) (162)
Thrombocytopenia in homosexual patients. Prognosis, response to therapy, and prevalence of antibody to the retrovirus associated with the acquired immunodeficiency syndrome. (1985) (161)
Complement-Independent, Peroxide-Induced Antibody Lysis of Platelets in HIV-1-Related Immune Thrombocytopenia (2001) (148)
Thrombin Induces the Release of Angiopoietin-1 from Platelets (2001) (144)
Role of Platelets, Thrombin, Integrin llb-llla, Fibronectin and Von Willebrand Factor on Tumor Adhesion in Vitro and Metastasis in Vivo (1995) (144)
Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia. (2008) (143)
Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells. (2002) (140)
Thrombocytopenic purpura in narcotics addicts. (1985) (139)
Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia. (2005) (137)
Cumulative experience in the detection of antiplatelet antibody in 234 patients with idiopathic thrombocytopenic purpura, systemic lupus erythematosus and other clinical disorders. (1972) (133)
Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells. (2000) (129)
Studies on human platelet glycolysis. Effect of glucose, cyanide, insulin, citrate, and agglutination and contraction on platelet glycolysis. (1967) (129)
Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 (HIV-1) infection. (1988) (122)
Autoimmune thrombocytopenic purpura and the compensated thrombocytolytic state. (1971) (120)
Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice. (1984) (119)
Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)amide. (1981) (114)
Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. (1998) (112)
The increased percentage of megathrombocytes in various clinical disorders. (1972) (112)
Detection of Splenic Anti‐Platelet Antibody Synthesis in Idiopathic Autoimmune Thrombocytopenic Purpura (ATP) (1972) (108)
Heterogeneity of Human Platelets: IV. IDENTIFICATION OF A YOUNG PLATELET POPULATION WITH [75Se]SELENOMETHIONINE (1971) (107)
Platelet function and coagulation profile in lupus erythematosus. Studies in 50 patients. (1974) (107)
Thrombin up-regulates cathepsin D which enhances angiogenesis, growth, and metastasis. (2008) (103)
REGULATION OF GLYCOLYSIS IN MUSCLE. II. EFFECT OF STIMULATION AND EPINEPHRINE IN ISOLATED FROG SARTORIUS MUSCLE. (1964) (100)
Thrombin Induces Increased Expression and Secretion of VEGF from Human FS4 Fibroblasts, DU145 Prostate Cells and CHRF Megakaryocytes (2001) (98)
Platelet Counts in Infants of Women with Autoimmune Thrombocytopenia (1981) (98)
Thrombin Inhibits Tumor Cell Growth in Association with Up-regulation of p21 waf/cip1 and Caspases via a p53-independent, STAT-1-dependent Pathway* (2000) (95)
Thrombin stimulates melanoma tumor‐cell binding to endothelial cells and subendothelial matrix (2009) (93)
The effect of azidothymidine on HIV-related thrombocytopenia. (1988) (91)
Autoimmune (idiopathic) thrombocytopenic purpura (1997) (88)
Easy bruising, thrombocytopenia, and elevated platelet immunoglobulin G in Graves' disease and Hashimoto's thyroiditis. (1981) (87)
Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts. (1988) (86)
Thrombin induces neoangiogenesis in the chick chorioallantoic membrane (2003) (85)
Human immunodeficiency virus infection and thrombotic microangiopathy. (1997) (85)
Anti-F(ab')2 antibodies in thrombocytopenic patients at risk for acquired immunodeficiency syndrome. (1986) (85)
A solid-phase radioimmunoassay for bound anti-platelet antibody: studies on 45 patients with autoimmune platelet disorders. (1979) (84)
Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis. (2006) (82)
Role of iron as a regulator of thrombopoiesis. (1974) (82)
Red-cell and platelet fragmentation in idiopathic autoimmune thrombocytopenic purpura. (1977) (81)
Heterogeneity of human fibrinogen: possible relation to proteolysis by thrombin and plasmin as studies by SDS-polyacrylamide gel electrophoresis. (1970) (78)
ROLE OF PLATELETS IN TUMOR CELL METASTASES (1981) (77)
A monoclonal anti-platelet antibody with decreased reactivity for autoimmune thrombocytopenic platelets. (1983) (77)
Microthrombocytosis and Platelet Fragmentation Associated with Idiopathic/Autoimmune Thrombocytopenic Purpura (1975) (76)
Human platelet senescence. (1972) (75)
Antiplatelet treatment of thrombotic thrombocytopenic purpura. (1977) (74)
Human megakaryocytes have a CD4 molecule capable of binding human immunodeficiency virus-1. (1993) (74)
Extraction and characterization of a platelet-aggregating material from SV40-transformed mouse 3T3 fibroblasts. (1979) (74)
Biochemical energetics of simulated platelet plug formation. Effect of thrombin, adenosine diphosphate, and epinephrine on intra- and extracellular adenine nucleotide kinetics. (1968) (72)
Autoimmune thrombocytopenic purpura (1971) (72)
Heterogeneity of platelet function. Correlation with platelet volume. (1978) (72)
Heterogeneity of Rabbit Platelets (1975) (71)
Heterogeneity of Human Platelets III. GLYCOGEN METABOLISM IN PLATELETS OF DIFFERENT SIZES (1970) (71)
Biochemical and biophysical aspects of human platelet adhesion to collagen fibers. (1971) (69)
Identification of a family of alternatively spliced mRNA species of angiopoietin-1. (2000) (66)
Expression of CD4 by human megakaryocytes. (1990) (66)
Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway. (2004) (65)
GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia. (1997) (64)
Twist is required for thrombin-induced tumor angiogenesis and growth. (2008) (63)
A new mechanism for tumor‐induced platelet aggregation. Comparison with mechanisms shared by other tumors with possible pharmacologic strategy toward prevention of metastases (1983) (62)
The development of human megakaryocytes: III. Development of mature megakaryocytes from highly purified committed progenitors in synthetic culture media and inhibition of thrombopoietin-induced polyploidization by interleukin-3. (1997) (62)
Autoimmune anti-HIV-1gp120 antibody with antiidiotype-like activity in sera and immune complexes of HIV-1-related immunologic thrombocytopenia. (1992) (61)
Heterogeneity of human platelets. V. Differences in glycolytic and related enzymes with possible relation to platelet age. (1972) (60)
Platelets and microtubules. Effect of colchicine and D2O on platelet aggregation and release induced by calcium ionophore A23187. (1980) (59)
Elevated platelet count and megathrombocyte number in sickle cell anemia. (1975) (57)
Heterogeneity of Rabbit Platelets. I. Employment of an Albumin Density Gradient for Separation of a Young Platelet Population Identified with Se75-Selenomethionine (1974) (57)
Thrombin induces tumor cell cycle activation and spontaneous growth by down-regulation of p27Kip1, in association with the up-regulation of Skp2 and MiR-222. (2009) (55)
Association of HLA-DRw2 with autoimmune thrombocytopenic purpura. (1979) (53)
Immunologic thrombocytopenic purpura in HIV-seropositive homosexuals, narcotic addicts and hemophiliacs. (1988) (52)
Soluble and Particulate Hexokinase of Frog Skeletal Muscle (1967) (51)
Antiidiotype Antibody against Platelet Anti-Gpiiia Contributes to the Regulation of Thrombocytopenia in HIV-1–Itp Patients (2000) (51)
C-terminal ADAMTS-18 fragment induces oxidative platelet fragmentation, dissolves platelet aggregates, and protects against carotid artery occlusion and cerebral stroke. (2009) (50)
Crossed immunoelectrophoresis of human platelet membranes. The major antigen consists of a complex of glycoproteins, GPIIb and GPIIIa, held together by Ca2+ and missing in Glanzmann's thrombasthenia. (1982) (50)
Lack of effect of in vivo prostacyclin on the development of pulmonary metastases in mice following intravenous injection of CT26 colon carcinoma, Lewis lung carcinoma, or B16 amelanotic melanoma cells. (1984) (49)
Hematopoiesis and stem cell renewal in long-term bone marrow cultures containing catalase. (2004) (48)
Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients. (1995) (48)
Heavy chain subclass of human anti-platelet antibodies. (1973) (47)
Drug-dependent and non-drug-dependent antiplatelet antibody in drug-induced immunologic thrombocytopenic purpura. (1985) (46)
Deficiency of glutathione peroxidase associated with high levels of reduced glutathione in glanzmann's thrombasthenia. (1972) (45)
Heterogeneity of human platelets. VII. Platelet monoamine oxidase activity in normals and patients with autoimmune thrombocytopenic purpura and reactive thrombocytosis: its relationship to platelet protein density. (1978) (45)
Platelet and Coagulation Defects Associated with HIV-1-Infection (2002) (44)
Risk for the acquired immunodeficiency syndrome among thrombocytopenic and nonthrombocytopenic homosexual men seropositive for the human immunodeficiency virus. (1987) (44)
Heterogeneity of Rabbit Platelets (1978) (43)
The platelet factor 3 immunoinjury technique re-evaluated. Development of a rapid test for antiplatelet antibody. Detection in various clinical disorders, including immunologic drug-induced and neonatal thrombocytopenias. (1977) (43)
Platelet counts in infants of women with autoimmune thrombocytopenia: effects of steroid administration to the mother. (1982) (42)
Growth regulated oncogene is pivotal in thrombin-induced angiogenesis. (2006) (41)
HIV-1-related thrombocytopenia. (1990) (41)
The role of tumor-induced platelet aggregation, platelet adhesion and adhesive proteins in tumor metastasis. (1988) (40)
Indirect immunofluorescence assay for antibodies to human immunodeficiency virus (1987) (40)
Hypersplenic thrombocytopenia differentiated from increased peripheral destruction by platelet volume. (1978) (39)
Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor. (1998) (38)
Role of thrombin as a tumor growth factor (2010) (38)
Heavy-chain subclass of round antiplatelet IgG in autoimmune thrombocytopenic purpura. (1980) (36)
The megathrombocyte as an index of platelet production. (1974) (35)
Plasma requirement for the aggregation of rabbit platelets by an aggregating material derived from SV40-transformed 3T3 fibroblasts. (1980) (34)
Presence of a nonsplenic platelet pool. (1977) (34)
Association of antiplatelet antibody with functional platelet disorders. Autoimmune thrombocytopenic purpura, systemic lupus erythematosus and thrombopathia. (1975) (34)
On the "easy bruising" syndrome with normal platelet count. A study of 75 patients. (1975) (33)
Crossed immunoelectrophoresis of human platelet membranes. Diminished major antigen in Glanzmann's thrombasthenia and Bernard-Soulier syndrome. (1980) (32)
Drug-induced thrombocytopenia. (1971) (32)
The initial macromolecular derivatives of human fibrinogen produced by plasmin. (1972) (32)
Requirement of iron for platelet protein synthesis. (1973) (31)
SHOULD ALL PREGNANT WOMEN BE TESTED FOR THEIR PLATELET PLA (Zw, HPA‐1) PHENOTYPE? (1994) (30)
Glycogenesis and glyconeogenesis in human platelets. Incorporation of glucose, pyruvate, and citrate into platelet glycogen; glycogen synthetase and fructose-1,6-diphosphatase activity. (1970) (30)
Development of human megakaryocytes: I. Hematopoietic progenitors (CD34+ bone marrow cells) are enriched with megakaryocytes expressing CD4. (1996) (29)
Immunologic thrombocytopenic purpura in human immunodeficiency virus--seropositive patients with hemophilia. Comparison with patients with classic autoimmune thrombocytopenic purpura, homosexuals with thrombocytopenia, and narcotic addicts with thrombocytopenia. (1988) (29)
The non-plasmin, proteolytic origin of human fibrinogen heterogeneity. (1971) (28)
Impaired lymphocyte transformation and capping in autoimmune thrombocytopenic purpura. (1979) (28)
Heterogeneity of rabbit platelets. II. Use of the megathrombocyte to demonstrate a thrombopoietic stimulus. (1974) (27)
A 13-mer peptide straddling the leucine33/proline33 polymorphism in glycoprotein IIIa does not define the PLA1 epitope (1991) (26)
Differentiation of autoimmune thrombocytopenia from thrombocytopenia associated with immune complex disease: systemic lupus erythematosus, hepatitis‐cirrhosis, and HIV‐1 infection by platelet and serum immunological measurements (1999) (26)
Hereditary autoimmune thrombocytopenic purpura: an immunologic and genetic study. (1981) (25)
Platelet particle formation by anti GPIIIa49-66 Ab, Ca2+ ionophore A23187, and phorbol myristate acetate is induced by reactive oxygen species and inhibited by dexamethasone blockade of platelet phospholipase A2, 12-lipoxygenase, and NADPH oxidase. (2007) (24)
Cumulative experience with a simplified solid-phase radioimmunoassay for the detection of bound antiplatelet IgG, serum auto-, allo-, and drug-dependent antibodies. (1982) (24)
Abnormal autologous mixed lymphocyte reaction in autoimmune thrombocytopenic purpura. (1982) (24)
BIOCHEMICAL and CLINICAL ASPECTS OF MEGATHROMBOCYTES (1972) (24)
Immunologic thrombocytopenic purpura after heterosexual transmission of human immunodeficiency virus (HIV). (1988) (23)
Complementary and antagonistic effects of IL‐3 in the early development of human megakaryocytes in culture (1998) (22)
Hypercoagulability preceding cancer (2005) (22)
Expression of CD41 and c‐mpl does not indicate commitment to the megakaryocyte lineage during haemopoietic development (1999) (21)
A 13-mer peptide straddling the leucine33/proline33 polymorphism in glycoprotein IIIa does not define the PLA1 epitope. (1991) (20)
In vitro suppressor T lymphocyte dysfunction in autoimmune thrombocytopenic purpura associated with a complement‐fixing antibody (1990) (20)
Crossed immunoelectrophoresis of human platelet membranes. (1992) (19)
Autoimmune thrombocytopenic purpura. (1985) (19)
Studies of the origin of platelet-associated fibrinogen. (1984) (19)
Platelet Fragmentation Requires a Specific Structural Conformation of Human Monoclonal Antibody against β3 Integrin* (2008) (19)
Role of platelet integrin GPIIb-GPIIIa, fibronectin, von Willebrand factor, and thrombin in platelet-tumor interaction in vitro and metastasis in vivo. (1994) (18)
GPIIIa-related PLA1 antigens with different molecular weights: studies in platelets, endothelial cells, and megakaryocytes (1988) (18)
B-cell subsets and platelet counts in HIV-1 seropositive subjects (1992) (17)
Dissolution of arterial platelet thrombi in vivo with a bifunctional platelet GPIIIa49-66 ligand which specifically targets the platelet thrombus. (2010) (17)
Evidence for a Humoral Agent Capable of Raising Vitamin–K–Dependent Coagulation Factors in Rabbits (1973) (16)
The Combining Ability of Glycoproteins IIb, IIIa and Ca2+ in EDTA-Treated Nonaggregable Platelets (1983) (16)
Internal-image anti-idiotype HIV-1gp120 antibody in human immunodeficiency virus 1 (HIV-1)-seropositive individuals with thrombocytopenia. (1992) (16)
The development of human megakaryocytes. II. CD4 expression occurs during haemopoietic differentiation and is an early step in megakaryocyte maturation (1996) (15)
Human platelet phosphorylase. (1969) (15)
Development of a monoclonal antibody capable of differentiating platelet PLA1/PLA1, PLA1/PLA2 and PLA2/PLA2 genotypes (1992) (15)
Leukocyte migration inhibition of buffy coats from patients with autoimmune thrombocytopenic purpura when exposed to normal platelets: modulation by transfer factor. (1984) (15)
Correlation with Platelet Volume (1978) (15)
Immunologic thrombocytopenic purpura in patients at risk for AIDS. (1987) (14)
Effect of plasma, steroids, or steroid products on the adhesion of human opsonized thrombocytes to human leukocytes. (1975) (14)
Immune thrombocytopenia in children. (1981) (14)
Studies on the Specificity of Anti-Platelet Autoantibodies 1 (1974) (14)
Crossed immunoelectrophoresis of human platelet membranes. Effect of charge on association and dissociation of the glycoprotein GPIIb-GPIIIa membrane complex. (1986) (14)
Inhibition of the enzymatic activity of thrombin by concanavalin A. (1974) (14)
Humoral factor that specifically regulates prothrombin (factor II) levels (coagulopoietin-II). (1979) (14)
Inhibition of binding of anti-PLA1 antibodies to platelets with monoclonal antibody LK-4. Evidence for multiple PLA1 receptor sites on platelet GPIIIa. (1996) (13)
Evidence suggesting the regulation of a coagulation factor levels in rabbits by a transferable plasma agent. (1976) (13)
HIV-1-related thrombocytopenia. (1990) (13)
Effect of antibody binding and agglutination on human platelet glycolysis: comparison with thrombon and epinephrine. (1967) (13)
Role of leuCAM integrins and complement in platelet-monocyte rosette formation induced by immune complexes of human immunodeficiency virus-type 1-immune thrombocytopenic purpura patients. (1993) (13)
Role of Thrombin in Tumor Angiogenesis, Implantation, and Metastasis (2003) (12)
Serum platelet-reactive IgG of autoimmune thrombocytopenic purpura patients is not F(ab')2 mediated and a function of storage (1992) (12)
PLATELET HETEROGENEITY (1977) (12)
Heterogenous Mechanisms of Tumor Cell-Induced Platelet Aggregation with Possible Pharmacologic Strategy toward Prevention of Metastases (1984) (11)
Circulating large platelets. (1971) (11)
IDIOPATHIC THROMBOCYTOPENIC PURPURA IN HOMOSEXUAL MEN (1984) (11)
Heterogeneity of Rabbit Platelets (1975) (11)
6 HIV-1-related thrombocytopenia* (1990) (11)
Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor: dansylarginine N-(3-ethyl-1, 5-pentanediyl)amide. (1982) (11)
A monoclonal antibody (LK-4) which differentiates PLA1 from PLA2 platelet extracts but not intact platelets. (1992) (11)
Activation of inactive phosphorylase dimer and monomer from human platelets with magnesium adenosine triphosphate. (1969) (11)
Does hypercoagulability awaken dormant tumor cells in the host? (2004) (11)
The spleen and thrombocytopenia. (1983) (10)
Effect of warfarin on prothrombin synthesis and secretion in human Hep G2 cells. (1987) (10)
Lead poisoning after taking Pb acetate with suicidal intent. Report of a case with a discussion of the mechanism of anemia. (1961) (10)
Use of the megathrombocyte to demonstrate thrombopoietin. (1972) (10)
Effect of insulin and muscle contraction on protein synthesis in frog sartorius. (1967) (9)
GPIIIa-related PLA1 antigens with different molecular weights: studies in platelets, endothelial cells, and megakaryocytes. (1988) (9)
HETEROGENEITY OF PLATELETS (1984) (9)
Hypercoagulability preceding cancer. Does hypercoagulability awaken dormant tumor cells in the host? (2005) (9)
Thrombocytopenia and human immunodeficiency virus-1 infection. (1990) (9)
Thrombocyte and Megathrombocyte Kinetics during Thrombocytosis Induced by Acute and Chronic Blood Loss and by Iron Deficiency Diet (1972) (9)
Solubilization and partial purification of sarcoplasmic reticulum-bound hexokinase of frog skeletal muscle. (1971) (8)
Requirement of divalent cation for human platelet phosphorylase activity. (1970) (8)
Heterogenous inhibition of platelet aggregation by monoclonal antibodies binding to multiple sites on GPIIIa (1995) (8)
Heterogeneity of human adult and fetal fibrinogen: detection of derivatives indicative of thrombin proteolysis. (1972) (8)
CHAPTER 42 – Tumor Growth and Metastasis (2007) (8)
Reevaluation of the presence of the major antigen Ca++ complex in Bernard-Soulier syndrome platelets. Elastase degradation of the complex in Bernard-Soulier syndrome platelet preparations. (1983) (8)
Asialo platelets enhance thrombopoiesis. (1980) (8)
Regulation of autoimmune anti-platelet antibody-mediated adhesion of monocytes to platelet GPIIb/GPIIIa: effect of armed monocytes and the Mac-1 receptor. (1990) (7)
Serum platelet-reactive IgG of autoimmune thrombocytopenic purpura patients is not F(ab')2 mediated and a function of storage. (1992) (7)
Interconvertible molecular forms of soluble hexokinase in frog skeletal muscle. (1968) (7)
Heterogeneity of human platelets. Metabolic and kinetic evidence suggestive of young and old platelets. (1971) (7)
Effect of cancer on platelets. (2009) (7)
Severe Isolated Prothrombin Deficiency : an Acquired State with Complete Recovery (1962) (7)
In Vivo and In Vitro Binding of Factor VIII to Human Platelets (1969) (7)
Solid-phase radioimmunoassay for bound anti-platelet antibody. Studies on 45 patients with autoimmune platelet disorders. [/sup 125/I, PBI] (1979) (6)
Growth Regulated Oncogene (GRO-α) Is Pivotal in Thrombin-Induced Angiogenesis. (2005) (6)
The Role of Thrombin in Tumor Biology (2009) (6)
Globin synthesis in human reticulocytes. (1963) (6)
Effect of coumadin‐induced coagulopoietin plasma on vitamin K‐dependent carboxylation of liver microsomes (1983) (6)
Platelet aggregating material (PAM) of two virally-transformed tumors: SV3T3 mouse fibroblast and PW20 rat renal sarcoma. Role of cell surface sialylation. (1982) (5)
Detection of antiplatelet antibody activity in patients with renal cortical necrosis. (1974) (5)
Micromethod for demonstrating increased platelet surface immunoglobulin G: Findings in acute, chronic, and human immunodeficiency virus‐1‐related immunologic thrombocytopenias (1990) (5)
Humoral factor that specifically regulates factor X levels in rabbits (coagulopoietin-X). (1979) (5)
Production of a human anti-CD4 monoclonal antibody with antiidiotype to anti-HIV type 1 glycoprotein 120. (1995) (4)
Posttransfusion Purpura: Conversion of PLA1-Negative Platelets to the PLA1-Positive Phenotype by Stored Plasma is not due to the Presence of Soluble PLA1 Antigen (1990) (4)
Short Communication: Elevated Platelet Count and Megathrombocyte Number in Sickle Cell Anemia (1975) (4)
Treatment of Thrombocytopenia in Chimpanzees Infected With Human Immunodeficiency Virus by Pegylated Recombinant Human Megakaryocyte Growth and Development Factor (1998) (4)
Heterogeneity of rabbit platelets. Effect of chronic blood loss on glycolytic and related enzyme activity. (1974) (3)
Evidence for colchicine-dependent protease activity in human platelets. (1981) (3)
Idiopathic Autoimmune Thrombocytopenic Purpura (1970) (3)
The Orphan Receptor GPR31 Is the Platelet and HUVEC Receptor for 12(S)-HETE (2008) (3)
Identification of a coagulopoietin for prothrombin. (1978) (3)
Autoimmune thrombocytopenia and AIDS-related thrombocytopenia. (1990) (3)
RAPID Association of HLA-DRw2 with Autoimmune Thrombocytopenic Purpura (3)
Autoimmune Thrombocytopenias (2004) (2)
HUMORAL SUBSTANCES REGULATING THE LEVELS OF COAGULATION FACTORS: COAGULOPOIETINS * (1981) (2)
Crossed Immunoelectrophoresis In The Identification Of Platelet Membrane Glycoproteins And Complexes (1981) (2)
The Molecular Components and Fibrinolytic Activity of Human Thrombin (1973) (2)
Letter: Platelet-antibody synthesis. (1973) (1)
Significance of Platelet Volume Measurements (1977) (1)
A New Mechanism of Platelet Activation, Oxidation and Death Induced by ADAMTS-18. (2005) (1)
Platelets and Cancer (2004) (1)
Thrombin stimulates both platelets and tumor cells to adhere to each other (1989) (1)
Thrombin Enhances Spontaneous Tumor Growth and Cell Cycle Activation by Downregulation of p27 Kip1 and Upregulation of Skp2 and MiR-222 (2008) (1)
Association of HLA-DRw2 with Autoimmune (1979) (1)
A New Mechanism of Platelet Activation and Oxidative Death Induced by ADAMTS-18 and Regulating Bleeding Time. (2007) (1)
A Solid Phase Radio-Immuno Assay for Platelet-Bound IgG Employing 125-I protein Extraction of 7S IgG and Identification of Its Subclasses (1979) (1)
Cytokine GRO-a is pivotal in thrombin-induced angiogenesis (2009) (1)
Evidence for a Splenic Release Factor of Platelets in Chronic Blood Loss Plasma of Rabbits (1976) (1)
MECHANISMS OF IMMUNOLOGIC THROMBOCYTOPENIA IN INDIVIDUALS AT RISK FOR AIDS (1987) (1)
Regulation of Glycolysis in Skeletal Muscle (2008) (1)
Regulation of blood coagulation factor levels in plasma. (1985) (0)
human immunodeficiency virus-1 Human megakaryocytes have a CD4 molecule capable of binding (2011) (0)
CHAPTER 42 – Thrombocytopenic Purpura (2006) (0)
THROMBOPOIETIN ASSAYS (1977) (0)
immunologic thrombocytopenia related - Role of molecular mimicry to HIV-1 peptides in HIV-1 (2013) (0)
containing catalase Hematopoiesis and stem cell renewal in long-term bone marrow cultures (2013) (0)
Marjorie Zucker, PhD, 1919–2006 (2006) (0)
Anti-Idiotype Antibody in HIV-1-Infected Thrombocytopenic Patients (1997) (0)
on platelet GPIIIa monoclonal antibody LK-4. Evidence for multiple PLA1 receptor sites Inhibition of binding of anti-PLA1 antibodies to platelets with (2012) (0)
Heterogeneity of Hum an Platelets (2005) (0)
1997 PEDIATRIC ACADEMIC SOCIETIES ’ ANNUAL MEETING SPONSORED BY THE AMERICAN PEDIATRIC Socnrr S 0 cIE ’ rY FOR PEDIATRIC RESEARCH AND AMULATORY PEDIATRIC ASSOCIATION (2004) (0)
Crossed Immunoelectrophoresis for the Study of Platelet Membrane Proteins (1991) (0)
The gamma heavy-chain subclass of bound antiplatelet antibody was examined in six patients with autoimmune thrombocytopenic purpura (ATP) by a solid-phase radioimmunoassay. Monospecific antisera for 'yGl (2011) (0)
MCP-1 muscles in on pericytes (2007) (0)
CELL-MEDIATED PLATELET RECOGNITION BY LEUKOCYTES FROM INDIVIDUALS WITH AUTOIMMUNE THROMBOCYTOPENIA AND ITS SUPPRESSION BY HUMAN AND ANIMAL TRANSFER FACTOR (1984) (0)
patients immunodeficiency virus- type 1-immune thrombocytopenic purpura rosette formation induced by immune complexes of human Role of leuCAM integrins and complement in platelet-monocyte (2013) (0)
Platelets in Hematologic and Cardiovascular Disorders: Platelets in other thrombotic conditions (2007) (0)
Thrombin Contributes to the Tumor Promalignant Phenotype by Upregulation of Cathepsin D Which Stimulates Angiogenesis. (2007) (0)
Role of thrombin in angiogenesis: reply to a rebuttal (2004) (0)
Platelet Function and Coagulation Profile in Lupus Erythematosus (2020) (0)
Requirement of a Plasma Factor for Platelet Aggregating Material (PAM) Extracted from Tumor Cells (1979) (0)
Thrombocytopenia in Homosexual Patients (2020) (0)
Dexamethasone (Dex) Inhibits Anti-GPIIIa49-66 Ab Induced Oxidative Fragmenation of Platelets: Inhibition of Platelet Phospholipase A2 (PLA2) and 12-Lipoxygenase (12-LO) MembraneTranslocation and Activity. (2006) (0)
Tieing a Tie-2 ligand to Weibel-Palade bodies (2004) (0)
Determination of Carboxypeptidase in Human Pancreatic Juice.∗ (1959) (0)
Cancer Metastasis: Role of Platelets and Thrombin in Metastasis (2011) (0)
Factor Levels in Rabbits by a Transferable Plasma Agent (2016) (0)
Souvenirs: Around the World in Ninety Years (1999) (0)
Human Platelet Senescence Study. (1980) (0)
Twist Is Required for Thrombin-Induced Tumor Angiogenesis as Well as Migration. (2007) (0)
Platelet antibodies in autoimmune thrombocytopenia and drug-dependent thrombocytopenia. Cell-mediated immunity. HLA phenotyes. Evans' syndrome. (1978) (0)
ANNOTATION (1948) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Simon Karpatkin?

Simon Karpatkin is affiliated with the following schools:

New York University